Next Wave in Immune Therapeutics: From suppression to re-balancing the immune system (Johnson & Johnson)

At Johnson & Johnson Innovation, they seek to collaborate with early-stage companies and researchers to generate transformational healthcare solutions that can bring value to patients.

Given the travel and safety regulations in place to combat the coronavirus COVID-19 pandemic, the Johnson & Johnson Innovation team will host on 29-30 September a virtual scientific and partnering event on state-of-the-art developments in immunology, bringing together entrepreneurs, start-ups, researchers, and scientists from across Europe and beyond.

The event will include:

  • a keynote on their latest innovations in immunology
  • a panel discussion with European thought leaders in the field
  • a briefing on the Johnson & Johnson Innovation model for supporting scientists and entrepreneurs
  • one-to-one partnering meetings between the Johnson & Johnson Innovation team and selected companies, researchers or other organizations

Registrations for the actual event will be accepted until the event kick-off on 29 September at 15:00 CEST.  The meeting application form will remain open until 16 October.